Latest News & Features
Big Pharma
Bid to stay invalidity decision pending a SCOTUS appeal fails | Patent covers a multiple sclerosis drug | Company could take $300m hit if generics are launched. 29 September 2022
Biotechnology
The lawsuit centres on patented molecular instruments | The patents-in-suit cover cover features of RNAscope tech. 27 September 2022
Americas
Pharma firm beats back digital health company over migraine tracking app / Indiana’s Uniform Trade Secrets Act cited by US judge. 27 September 2022
article
Law firm Finnegan has announced that partner Scott Burwell has been appointed as the firm’s partner-in-charge of diversity, equity, and inclusion. 27 September 2022
article
IP law firm Powell Gilbert has expanded its life sciences team with the appointment of James Bergus. 22 September 2022
Biotechnology
Evidence shows medicines approved as biosimilars in the EU may be prescribed interchangeably | Additional ‘switch’ studies no longer not need to be carried out. 22 September 2022
Americas
Federal Circuit denies petition to rehear dispute over multiple sclerosis medicine | Company will petition highest court over invalidity ruling. 22 September 2022
Big Pharma
Pfizer’s ‘Breakthrough’ programme is aimed at Black, Latino and Native Americans | A healthcare membership organisation filed the complaint. 20 September 2022
Americas
Report found that four times as many patents are granted on the top ten drugs in the US, compared to Europe | Non-profit says that the US’ patent system is ‘broken’. 20 September 2022
Big Pharma
Authority carries out dawn raid at Novartis’ premises | Probe focuses on the alleged unlawful use of a skincare patent to bar competition 20 September 2022